Log in

NASDAQ:MLABMesa Laboratories Stock Price, Forecast & News

$243.48
+2.33 (+0.97 %)
(As of 08/4/2020 04:00 PM ET)
Add
Compare
Today's Range
$236.05
Now: $243.48
$246.98
50-Day Range
$208.55
MA: $223.47
$241.16
52-Week Range
$181.90
Now: $243.48
$271.46
Volume30,431 shs
Average Volume42,536 shs
Market Capitalization$1.24 billion
P/E Ratio593.85
Dividend Yield0.27%
Beta0.38
Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness. This segment's products are used in healthcare, pharmaceutical, medical device, food and beverage, industrial hygiene, and environmental air sampling industries. Its Sterilization and Disinfection Control segment manufactures and markets biological indicators comprising spore strips, self-contained products, and culture media, as well as process challenge devices; and testing services. This segment also distributes chemical indicators that are used to assess the effectiveness of sterilization processes; and cleaning indicators, which are used to assess the effectiveness of cleaning processes. The company's Cold Chain Monitoring segment offers systems, which are used to monitor various environmental parameters, such as temperature, humidity, and differential pressure for use in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and laboratory environments; parameter monitoring services for products in a cold chain; and consulting services. Its Cold Chain Packaging segment offers packaging development consulting services and thermal packaging products. The company markets its products through distributors in Europe, Africa, Asia, South America, Australia, Canada, and Central America. Mesa Laboratories, Inc. was founded in 1982 and is headquartered in Lakewood, Colorado.
Read More
Mesa Laboratories logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.6Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.48 out of 5 stars


Industry, Sector and Symbol

Industry Process control instruments
Sub-IndustryElectronic Equipment & Instruments
SectorMedical
Current SymbolNASDAQ:MLAB
CUSIP59064R10
Phone303-987-8000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$117.69 million
Cash Flow$10.23 per share
Book Value$50.34 per share

Profitability

Net Income$1.35 million

Miscellaneous

Employees366
Market Cap$1.24 billion
Next Earnings DateN/A
OptionableNot Optionable
$243.48
+2.33 (+0.97 %)
(As of 08/4/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MLAB News and Ratings via Email

Sign-up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Mesa Laboratories (NASDAQ:MLAB) Frequently Asked Questions

How has Mesa Laboratories' stock been impacted by COVID-19 (Coronavirus)?

Mesa Laboratories' stock was trading at $230.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MLAB shares have increased by 5.4% and is now trading at $243.48.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Mesa Laboratories?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mesa Laboratories in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Mesa Laboratories
.

How were Mesa Laboratories' earnings last quarter?

Mesa Laboratories, Inc. (NASDAQ:MLAB) posted its earnings results on Monday, June, 1st. The medical instruments supplier reported $0.06 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.21 by $0.15. The medical instruments supplier earned $34.21 million during the quarter, compared to analysts' expectations of $34.50 million. Mesa Laboratories had a net margin of 1.15% and a return on equity of 8.92%.
View Mesa Laboratories' earnings history
.

How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories?

Mesa Laboratories declared a quarterly dividend on Tuesday, July 7th. Shareholders of record on Monday, August 31st will be given a dividend of $0.16 per share on Tuesday, September 15th. This represents a $0.64 annualized dividend and a dividend yield of 0.26%. The ex-dividend date of this dividend is Friday, August 28th.
View Mesa Laboratories' dividend history
.

What price target have analysts set for MLAB?

2 analysts have issued 12 month price objectives for Mesa Laboratories' stock. Their forecasts range from $250.00 to $275.00. On average, they expect Mesa Laboratories' share price to reach $262.50 in the next year. This suggests a possible upside of 7.8% from the stock's current price.
View analysts' price targets for Mesa Laboratories
.

Has Mesa Laboratories been receiving favorable news coverage?

Media stories about MLAB stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Mesa Laboratories earned a media sentiment score of 0.8 on InfoTrie's scale. They also assigned news articles about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the near future.
View the latest news about Mesa Laboratories
.

Who are some of Mesa Laboratories' key competitors?

What other stocks do shareholders of Mesa Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mesa Laboratories investors own include NVIDIA (NVDA), Verizon Communications (VZ), Alibaba Group (BABA), Gilead Sciences (GILD), Intel (INTC), Coupa Software (COUP), Altria Group (MO), Micron Technology (MU), Exxon Mobil (XOM) and Appian (APPN).

Who are Mesa Laboratories' key executives?

Mesa Laboratories' management team includes the following people:
  • Mr. Gary M. Owens, CEO, Pres & Director (Age 51)
  • Mr. John V. Sakys, Chief Financial Officer, Chief Accounting Officer, Sec. & Treasurer (Age 50)
  • Mr. Gregory T. DiNoia, Sr. VP of Commercial Operations (Age 54)
  • Ms. Helene R. Leone, Gen. Counsel
  • Mr. Peter Jung, VP of Corp. Devel. & Strategy

What is Mesa Laboratories' stock symbol?

Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."

Who are Mesa Laboratories' major shareholders?

Mesa Laboratories' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Conestoga Capital Advisors LLC (9.38%), Moody Aldrich Partners LLC (1.02%), Comerica Bank (0.51%), Raymond James Financial Services Advisors Inc. (0.31%), Raymond James & Associates (0.20%) and Foundry Partners LLC (0.17%). Company insiders that own Mesa Laboratories stock include Brian David Archbold, David M Kelly, Evan Guillemin, John Bradley Schmieder, John James Sullivan, John Sakys, Michael T Brooks, Robert V Dwyer and Seg Ventures, Llc.
View institutional ownership trends for Mesa Laboratories
.

Which major investors are selling Mesa Laboratories stock?

MLAB stock was sold by a variety of institutional investors in the last quarter, including Comerica Bank, UBS Group AG, Foundry Partners LLC, Texas Permanent School Fund, and Brinker Capital Inc.. Company insiders that have sold Mesa Laboratories company stock in the last year include Brian David Archbold, Evan Guillemin, John Bradley Schmieder, John James Sullivan, and Robert V Dwyer.
View insider buying and selling activity for Mesa Laboratories
.

Which major investors are buying Mesa Laboratories stock?

MLAB stock was acquired by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC, Raymond James & Associates, Moody Aldrich Partners LLC, First Trust Advisors LP, SG Americas Securities LLC, Exchange Traded Concepts LLC, Quantitative Systematic Strategies LLC, and Everence Capital Management Inc..
View insider buying and selling activity for Mesa Laboratories
.

How do I buy shares of Mesa Laboratories?

Shares of MLAB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Mesa Laboratories' stock price today?

One share of MLAB stock can currently be purchased for approximately $243.48.

How big of a company is Mesa Laboratories?

Mesa Laboratories has a market capitalization of $1.24 billion and generates $117.69 million in revenue each year. The medical instruments supplier earns $1.35 million in net income (profit) each year or $4.21 on an earnings per share basis. Mesa Laboratories employs 366 workers across the globe.

What is Mesa Laboratories' official website?

The official website for Mesa Laboratories is www.mesalabs.com.

How can I contact Mesa Laboratories?

Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The medical instruments supplier can be reached via phone at 303-987-8000 or via email at [email protected]

This page was last updated on 8/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.